文献速递物质与行为成瘾

Kappa阿片受体与纳曲酮所致饮酒及渴求减少相关

The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving.
PubMed 文献 · Biol Psychiatry · 2019-06-08

该研究纳入48名符合DSM-IV酒精依赖标准的非治疗寻求重度饮酒者,先进行基线KOR PET成像,再经一周开放标签纳曲酮(100 mg/日)后开展第二次饮酒范式。结果显示纳曲酮后渴求与饮酒量显著下降,且饮酒减少与基线纹状体、苍白球、扣带皮层KOR可用性负相关;所有评估脑区KOR可用性均与两次范式中的渴求相关。

要点

  • 纳曲酮治疗后渴求与饮酒量显著下降。
  • 基线纹状体、苍白球、扣带皮层KOR可用性越低,饮酒减少越明显。
  • 所有评估脑区KOR可用性均与两次范式中的渴求相关。

核心结论

  • KOR参与酒精使用障碍患者纳曲酮治疗后的饮酒与渴求过程。

研究设计与样本

  • 48名符合DSM-IV酒精依赖标准的非治疗寻求重度饮酒者(16名女性)完成两次饮酒范式,间隔一周开放标签纳曲酮(100 mg/日)。
  • 纳曲酮启动前使用[11C]LY2795050 PET测定杏仁核、海马、苍白球、纹状体、扣带皮层和前额叶皮层的KOR可用性。

主要发现

  • 纳曲酮后第二次饮酒范式渴求降低(Yale Craving Scale:-11 ± 1,p < .0001;Alcohol Urge Questionnaire:-6 ± 0.6,p < .0001)。
  • 纳曲酮后第二次饮酒范式饮酒量减少(-3.7 ± 4,p < .0001)。
  • 饮酒减少与基线KOR可用性在纹状体(p = .005)、苍白球(p = .023)和扣带皮层(p = .018)呈负相关。
  • 体素分析发现双侧岛叶、前额叶和扣带皮层簇与饮酒减少相关(p < .0001)。
  • 所有评估脑区KOR可用性均与两次饮酒范式中的渴求相关。

临床怎么用

  • 基线KOR可用性可能作为纳曲酮治疗酒精使用障碍疗效的潜在生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Naltrexone is a nonselective opioid receptor antagonist used as a treatment for alcohol use disorder. However, only modest clinical effects have been observed, possibly because of limited knowledge about the biological variables affecting the efficacy of naltrexone. We investigated the potential role of the kappa opioid receptor (KOR) in the therapeutic effect of naltrexone. METHODS: A total of 48 non-treatment-seeking heavy drinkers (16 women) who met DSM-IV criteria for alcohol dependence participated in two alcohol drinking paradigms (ADPs) separated by a week of open-label naltrexone (100 mg daily). Craving, assessed with the Alcohol Urge Questionnaire and the Yale Craving Scale, and drinking behavior were recorded in each ADP. Prior to naltrexone initiation, KOR availability was determined in the amygdala, hippocampus, pallidum, striatum, cingulate cortex, and prefrontal cortex using positron emission tomography with [11C]LY2795050. RESULTS: Participants reported lower levels of craving (Yale Craving Scale: -11 ± 1, p < .0001; Alcohol Urge Questionnaire: -6 ± 0.6, p < .0001) and consumed fewer drinks (-3.7 ± 4, p < .0001) during the second ADP following naltrexone therapy. The observed reduction in drinking was negatively associated with baseline KOR availability in the striatum (p = .005), pallidum (p = .023), and cingulate cortex (p = .018). Voxelwise analysis identified clusters in the bilateral insula, prefrontal, and cingulate cortex associated with the reduction in drinking (p < .0001). In addition, KOR availability in all evaluated brain regions was associated with craving measured in both ADPs. CONCLUSIONS: The KOR is implicated in drinking and craving following naltrexone therapy in alcohol use disorder.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. de Laat B, Goldberg A, Shi J, et al. The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving. Biol Psychiatry. 2019. PMID: 31399255. doi:10.1016/j.biopsych.2019.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。